| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/27/2007 | US20070225318 Pyrazole Compounds Useful In The Treatment Of Inflammation |
| 09/27/2007 | US20070225317 Rsv polymerase inhibitors |
| 09/27/2007 | US20070225316 Methods and compositions for treating schizophrenia |
| 09/27/2007 | US20070225315 Methods of Treating Muscular Wasting Diseases Using NF-kB Activation Inhibitors |
| 09/27/2007 | US20070225314 Novel forms of tiotropium bromide and processes for preparation thereof |
| 09/27/2007 | US20070225313 Epimers and isomers of tetrazole containing rapamycin analogs, methods of making and using the same |
| 09/27/2007 | US20070225312 Terguride / proterguride for the treatment of chronic pain |
| 09/27/2007 | US20070225311 Condensation of 7-t-butoxyiminomethylcamptothecin in position 20 with a cyclopeptide containing the RGD sequence; selective cytotoxic activity on human tumor cell lines; antitumor; |
| 09/27/2007 | US20070225310 Antiviral methods and compositions |
| 09/27/2007 | US20070225309 Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors |
| 09/27/2007 | US20070225308 2-Amino Quinazoline Derivative |
| 09/27/2007 | US20070225307 C-met modulators and method of use |
| 09/27/2007 | US20070225306 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs |
| 09/27/2007 | US20070225305 Preparation of ester of purine derivatives |
| 09/27/2007 | US20070225304 Aminopurine derivatives for treating neurodegenerative diseases |
| 09/27/2007 | US20070225303 8-Oxoadenine Compound |
| 09/27/2007 | US20070225302 2-Amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purines as antiviral agents |
| 09/27/2007 | US20070225301 Treatment of acne and other diseases |
| 09/27/2007 | US20070225300 HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL -6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES |
| 09/27/2007 | US20070225299 Novel Combination Containing a Stimulator of Soluble Guanylate Cyclase and a Lipid-Lowering Substance |
| 09/27/2007 | US20070225297 Deuterated hepatitis C protease inhibitors |
| 09/27/2007 | US20070225296 Arylalkylamine Compound and Process for Preparing the Same |
| 09/27/2007 | US20070225295 Ziprasidone Hydrochloride Polymorph and Process for Its Preparation |
| 09/27/2007 | US20070225294 2-[4-({[4-{[4-(4-acetylphenyl)-1-piperazinyl]methyl}-2-(4-fluorophenyl)-1,3-thiazol-5-yl]methyl}sulfanyl)-2-methylphenoxy]-2-methylpropanoic acid; dyslipidemia, syndrome X, hypercholesteremia, type II diabetes mellitus, type I diabetes, insulin resistance, hyperlipidemia, and obesity |
| 09/27/2007 | US20070225293 Use of C-Kit Inhibitors for Treating Fibrosis |
| 09/27/2007 | US20070225292 Therapeutic Compounds: Pyridine as Scaffold |
| 09/27/2007 | US20070225290 Tetrahydronaphthalene derivates, processes for preparing them and their use as antiinflammatory agents |
| 09/27/2007 | US20070225289 Topoisomerase inhibitors; useful as antibacterial, antifungal agents; cancer; structure is based on substituted benzo(i)phenanthridine ring where the ring carbon atoms at position 5 and 11 are optionally replaced by nitrogen |
| 09/27/2007 | US20070225288 Indene Derivatives and Process for the Preparation Thereof |
| 09/27/2007 | US20070225287 Substituted Arylpyrazines |
| 09/27/2007 | US20070225286 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs |
| 09/27/2007 | US20070225285 5-lipoxygenase-activating protein (flap) inhibitors |
| 09/27/2007 | US20070225284 Inhibitors of soluble adenylate cyclase |
| 09/27/2007 | US20070225283 Conformationally restricted urea inhibitors of soluble epoxide hydrolase |
| 09/27/2007 | US20070225282 thrombin inhibitors such as 3-cyano-6-(2,2-difluoro-2-phenyl-ethylamino)-2-{2-[(aminoiminomethyl)aminooxy]ethyl}aminocarbonylmethyl-pyridine-1-oxide, used for the prophylaxis or treatment of diseases and conditions related to thrombin activity in mammals |
| 09/27/2007 | US20070225281 6-Amino-1,4-dihydro-benzo[d][1,3]oxazin-2-ones and analogs useful as progesterone receptor modulators |
| 09/27/2007 | US20070225280 hydroxysteroid reductase inhibitors such as 2'-tert-butyl-2'H-[1,3']bipyrazolyl-4'-carboxylic acid (5-hydroxy-adamantan-2-yl)-amide, used for the treatment of non-insulin dependent diabetes mellitus and metabolic syndrome |
| 09/27/2007 | US20070225279 Therapeutic combinations for the treatment of depression |
| 09/27/2007 | US20070225278 Methods for treating cognitive and other disorders |
| 09/27/2007 | US20070225277 Treatment of pain |
| 09/27/2007 | US20070225276 7-Phenylsulfonyl-Tetrahydro-3-Benzazepine Dervatives as Antipsychotic Agents |
| 09/27/2007 | US20070225275 Tetrahydro-pyrimidoazepines as modulators of TRPV1 |
| 09/27/2007 | US20070225274 Methods for modulating bladder function |
| 09/27/2007 | US20070225273 Malonamide derivatives |
| 09/27/2007 | US20070225272 CGRP receptor antagonists |
| 09/27/2007 | US20070225271 Pyrimidine, quinazoline, pteridine and triazine derivatives |
| 09/27/2007 | US20070225270 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 09/27/2007 | US20070225268 Method to treat neoplasms via gadolinium stereotactic synchrotron radiation |
| 09/27/2007 | US20070225267 beta -secretase inhibitors such as N-{(1S,2S)-1-(3,5-Difluorobenzyl)-2-[(3R,5S,6R)-6-(2,2-dimethylpropoxy)-5-methylmorpholin-3-yl]-2-hydroxyethyl}-acetamide, used for the treatment of neurodegenerative disorders such as Alzheimer's disease |
| 09/27/2007 | US20070225266 Spiropiperidylrifamycins for the Treatment of Mycobacterial Infections |
| 09/27/2007 | US20070225265 Novel Macrocycles for the Treatment of Cancer |
| 09/27/2007 | US20070225264 Drug delivery means |
| 09/27/2007 | US20070225263 Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma |
| 09/27/2007 | US20070225262 Method for the treatment of acne |
| 09/27/2007 | US20070225261 Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 09/27/2007 | US20070225260 Amino-Propanol Derivatives |
| 09/27/2007 | US20070225259 Novel Thiazole Inhibitors of Fructose 1,6-Bishosphatase |
| 09/27/2007 | US20070225258 Compositions comprising bisphosphonate and an antifolate |
| 09/27/2007 | US20070225257 Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] Phosphonic Acid and Methods of Use Thereof |
| 09/27/2007 | US20070225256 Compound |
| 09/27/2007 | US20070225255 Use of Mitochondrially Targeted Antioxidant in the Treatment of Liver Diseases and Epithelial Cancers |
| 09/27/2007 | US20070225254 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide- based compounds |
| 09/27/2007 | US20070225253 Use of a trioxopyrimidine for the treatment and prevention of bronchial inflammatory diseases |
| 09/27/2007 | US20070225252 Ketogenic Saccharides |
| 09/27/2007 | US20070225251 Method for Treating or Inhibiting the Effects of Injuries or Diseases that Result in Neuronal Degeneration |
| 09/27/2007 | US20070225250 Cobalamin compositions for the treatment of cancer |
| 09/27/2007 | US20070225249 2'-Fluoronucleoside phosphonates as antiviral agents |
| 09/27/2007 | US20070225248 Oral dosage forms of gemcitabine derivatives |
| 09/27/2007 | US20070225247 (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide; stable under relative humidity stress |
| 09/27/2007 | US20070225246 O-acetyl-ADP-ribose non-hydrolyzable analogs |
| 09/27/2007 | US20070225245 Viral vector driven mutant bacterial cytosine deaminase gene and uses thereof |
| 09/27/2007 | US20070225243 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor |
| 09/27/2007 | US20070225241 Tfiis and gdown1 as targets for cancer therapy |
| 09/27/2007 | US20070225240 Screening Assay and Treatment |
| 09/27/2007 | US20070225239 Peptide nucleic acid conjugated to a neamine are used to prevent or treat a disease associated with an aberrant nucleic acid molecule; targets include the human immunodeficiency virus-1 genome and messenger RNA encoding angiotensis II, nuclear factor kappa, and platelet-derived growth factor |
| 09/27/2007 | US20070225238 Inhibitors of carbonyl reductase for treatment using anthracyclines |
| 09/27/2007 | US20070225237 Methods for the prevention and/or the treatment of glutamate cytotoxicity |
| 09/27/2007 | US20070225236 Methods for the prevention and/or the treatment of glutamate cytotoxicity |
| 09/27/2007 | US20070225235 Methods for the prevention and/or the treatment of glutamate cytotoxicity |
| 09/27/2007 | US20070225234 Topical formulation of oil-in-water type as a carrier for providing a reduced irritant effect |
| 09/27/2007 | US20070225233 Reducing the risk of chronic lung disease in infants |
| 09/27/2007 | US20070225232 Tetrahydro-Imidazo [1,5-A] Pyridyin Derivatives as Aldosterone Synthase Inhibitors |
| 09/27/2007 | US20070225229 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| 09/27/2007 | US20070225225 Use of natriuretic peptide receptor antagonists to treat ocular, otic and nasal edemetous conditions |
| 09/27/2007 | US20070225221 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 09/27/2007 | US20070225220 Antimicrobial composition |
| 09/27/2007 | US20070225217 Methods, compositions, and kits for the treatment of medical conditions |
| 09/27/2007 | US20070225214 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 09/27/2007 | US20070225213 Nucleic acid carriers for delivery of therapeutic agents |
| 09/27/2007 | US20070225203 Method and Composition for Preventing Multiple Organ Dysfunction Syndrome |
| 09/27/2007 | US20070225202 Methods for Identifying Modulators of Active Kit Tyrosine Kinase Receptor |
| 09/27/2007 | US20070224679 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 09/27/2007 | US20070224671 Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditions |
| 09/27/2007 | US20070224648 Methods and compositions for the diagnosis of treatment of type 2 diabetes |
| 09/27/2007 | US20070224636 Pyrrolo[1,2b]pyridazine compounds and their uses |
| 09/27/2007 | US20070224611 Inactivation method |
| 09/27/2007 | US20070224301 Compounds from an extract of Artemisia and methods for treating disorders |
| 09/27/2007 | US20070224300 Weight loss compositions using citrus peel extract and eurycoma longfolia |
| 09/27/2007 | US20070224299 Weight loss with citrus flavonoids |
| 09/27/2007 | US20070224298 Inhibiting 11(beta)-hsd1 with citrus flavonoids |